125 related articles for article (PubMed ID: 38579443)
1. Alpha-methyl CoA racemase (AMACR) reactivity across the spectrum of clear cell renal cell neoplasms.
Rotterova P; Alaghehbandan R; Skopal J; Rogala J; Slisarenko M; Strakova Peterikova A; Michalova K; Montiel DP; Farcas M; Ulamec M; Stransky P; Fiala O; Pitra T; Hora M; Michal M; Pivovarcikova K; Hes O
Ann Diagn Pathol; 2024 Mar; 71():152297. PubMed ID: 38579443
[TBL] [Abstract][Full Text] [Related]
2. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma.
Tretiakova MS; Sahoo S; Takahashi M; Turkyilmaz M; Vogelzang NJ; Lin F; Krausz T; Teh BT; Yang XJ
Am J Surg Pathol; 2004 Jan; 28(1):69-76. PubMed ID: 14707866
[TBL] [Abstract][Full Text] [Related]
3. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
4. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum.
Tretiakova M; Mehta V; Kocherginsky M; Minor A; Shen SS; Sirintrapun SJ; Yao JL; Alvarado-Cabrero I; Antic T; Eggener SE; Picken MM; Paner GP
Virchows Arch; 2018 Jul; 473(1):85-93. PubMed ID: 29770853
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.
Eichelberg C; Minner S; Isbarn H; Burandt E; Terracciano L; Moch H; Kell A; Heuer R; Chun FK; Sauter G; Fisch M; Tennstedt P
World J Urol; 2013 Aug; 31(4):847-53. PubMed ID: 22009118
[TBL] [Abstract][Full Text] [Related]
6. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.
Olgac S; Hutchinson B; Tickoo SK; Reuter VE
Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894
[TBL] [Abstract][Full Text] [Related]
7. Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: a rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential.
Yang B; Sun L; Cao WF; Qi LS; Guo YH; Sun Y
Diagn Pathol; 2023 Feb; 18(1):27. PubMed ID: 36810118
[TBL] [Abstract][Full Text] [Related]
8. Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
Fadare O; Parkash V; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Rawish KR; Hecht JL; Desouki MM
Hum Pathol; 2013 Dec; 44(12):2814-21. PubMed ID: 24119561
[TBL] [Abstract][Full Text] [Related]
9. Alpha-methyl CoA racemase expression in renal cell carcinomas.
Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
[TBL] [Abstract][Full Text] [Related]
10. Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics.
Pramick M; Ziober A; Bing Z
Ann Diagn Pathol; 2013 Oct; 17(5):437-40. PubMed ID: 23791764
[TBL] [Abstract][Full Text] [Related]
11. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia.
Aron M; Luthringer DJ; McKenney JK; Hansel DE; Westfall DE; Parakh R; Mohanty SK; Balzer B; Amin MB
Am J Surg Pathol; 2013 Dec; 37(12):1815-23. PubMed ID: 24225842
[TBL] [Abstract][Full Text] [Related]
12. Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.
Jiang Z; Fanger GR; Woda BA; Banner BF; Algate P; Dresser K; Xu J; Chu PG
Hum Pathol; 2003 Aug; 34(8):792-6. PubMed ID: 14506641
[TBL] [Abstract][Full Text] [Related]
13. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
14. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
Zhou M; Jiang Z; Epstein JI
Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
[TBL] [Abstract][Full Text] [Related]
15. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study.
Al-Ahmadie HA; Alden D; Fine SW; Gopalan A; Touijer KA; Russo P; Reuter VE; Tickoo SK
Am J Surg Pathol; 2011 Jul; 35(7):949-61. PubMed ID: 21677535
[TBL] [Abstract][Full Text] [Related]
16. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
Zhou M; Aydin H; Kanane H; Epstein JI
Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314
[TBL] [Abstract][Full Text] [Related]
17. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
18. AMACR Positive Papillary Renal Adenomatosis and Multifocal Papillary Carcinoma in End Stage Renal Disease.
Kansal S; Chopra P; Dhawan S
Indian J Surg Oncol; 2018 Jun; 9(2):247-250. PubMed ID: 29887709
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of HNF1β, Napsin A and P504S/Alpha-Methylacyl-CoA Racemase (AMACR) as markers of endometrial clear cell carcinoma.
Travaglino A; Raffone A; Arciuolo D; Santoro A; Inzani F; Di Maio A; Visiello U; Fulgione C; Guida M; Mollo A; Insabato L; Zannoni GF
Pathol Res Pract; 2022 Sep; 237():154019. PubMed ID: 35907281
[TBL] [Abstract][Full Text] [Related]
20. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
Griffin BB; Lin X
Cancer Cytopathol; 2021 Mar; 129(3):192-203. PubMed ID: 33036062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
